We are a rapidly growing scientific consulting business committed to fostering the growth of innovative non-traditional approaches to solve unmet medical needs. Our primary focus is to assist in the development of vaccines, therapeutics and diagnostics for infectious disease, immunological disorders, inflammation and cancer from early stage discovery to late stage development and licensure.
We are team committed to work with your company to identify the best development path for your product and guide your organization to establish successful collaborations with the lead stakeholders.
We are a team focused on strengthening your product development plans with the goal of regulatory approval of your product. Our experience interacting with regulatory agencies will help you plan for meetings, address questions and mitigate risk.
We are a team of scientists who have worked both sides of the non-dilutive funding sector in biotechnology. We proactively monitor research funding initiatives and have significant knowledge of the mechanisms and requirements to obtain these funds.
We are a team dedicated to exploring funding opportunities and resources that are specific to your development goals and help you engage with the officials responsible for administering these programs. We will develop an approach and discover places in your applications and proposals that you can improve to be more competitive.
Our team’s extensive knowledge of science and technology and network of contacts with leaders at universities, government agencies and industry will immediately benefit your organization by identifying the right collaborators to move your product closer to the market or the right partners to bring your technologies and products to advanced development and licensure.
We are team committed to work with your company to identify the best development path for your product and guide your organization to establish successful collaborations with the lead stakeholders.
We are a team focused on strengthening your product development plans with the goal of regulatory approval of your product. Our experience interacting with regulatory agencies will help you plan for meetings, address questions and mitigate risk.
We are a team of scientists who have worked both sides of the non-dilutive funding sector in biotechnology. We proactively monitor research funding initiatives and have significant knowledge of the mechanisms and requirements to obtain these funds.
We are a team dedicated to exploring funding opportunities and resources that are specific to your development goals and help you engage with the officials responsible for administering these programs. We will develop an approach and discover places in your applications and proposals that you can improve to be more competitive.
Our team’s extensive knowledge of science and technology and network of contacts with leaders at universities, government agencies and industry will immediately benefit your organization by identifying the right collaborators to move your product closer to the market or the right partners to bring your technologies and products to advanced development and licensure.
We are team committed to work with your company to identify the best development path for your product and guide your organization to establish successful collaborations with the lead stakeholders.
We are a team focused on strengthening your product development plans with the goal of regulatory approval of your product. Our experience interacting with regulatory agencies will help you plan for meetings, address questions and mitigate risk.
We are a team of scientists who have worked both sides of the non-dilutive funding sector in biotechnology. We proactively monitor research funding initiatives and have significant knowledge of the mechanisms and requirements to obtain these funds.
We are a team dedicated to exploring funding opportunities and resources that are specific to your development goals and help you engage with the officials responsible for administering these programs. We will develop an approach and discover places in your applications and proposals that you can improve to be more competitive.
Our team’s extensive knowledge of science and technology and network of contacts with leaders at universities, government agencies and industry will immediately benefit your organization by identifying the right collaborators to move your product closer to the market or the right partners to bring your technologies and products to advanced development and licensure.
We are team committed to work with your company to identify the best development path for your product and guide your organization to establish successful collaborations with the lead stakeholders.
We are a team focused on strengthening your product development plans with the goal of regulatory approval of your product. Our experience interacting with regulatory agencies will help you plan for meetings, address questions and mitigate risk.
We are a team of scientists who have worked both sides of the non-dilutive funding sector in biotechnology. We proactively monitor research funding initiatives and have significant knowledge of the mechanisms and requirements to obtain these funds.
We are a team dedicated to exploring funding opportunities and resources that are specific to your development goals and help you engage with the officials responsible for administering these programs. We will develop an approach and discover places in your applications and proposals that you can improve to be more competitive.
Our team’s extensive knowledge of science and technology and network of contacts with leaders at universities, government agencies and industry will immediately benefit your organization by identifying the right collaborators to move your product closer to the market or the right partners to bring your technologies and products to advanced development and licensure.
Valtech’s committed team of advisors have experience performing research and managing successful discovery, preclinical and clinical research programs in universities, government agencies, biotechnology companies and large pharmaceutical companies. Products that we have developed are now marketed and approved for preventive and therapeutic use for public health indications and positioned for emergency response.
